HOME > BUSINESS
BUSINESS
- Takeda Squeezes Projected Losses for FY2019 as Velcade Copy Lags
August 1, 2019
- Eisai Posts Flat Revenue in Q1, Lenvima Sales Double
August 1, 2019
- Daiichi Sankyo Logs Double-Digit Growth in Q1 as Olmetec Cliff Tails Off; Profit Zooms on AZ Deal, Asset Sale
August 1, 2019
- Medipal to Buy Back Shares from Takeda
August 1, 2019
- After 3rd PIII Try, Sumitomo Dainippon Finally Files Latuda for Japan Approval
August 1, 2019
- US FDA Accepts Sunovion’s Dasotraline Submission for Binge Eating Disorder
August 1, 2019
- Oita Univ. Spinout, Daiichi Sankyo Tie Up on Peptide Mimetics Research
July 31, 2019
- Crushing Defeat or Sign of Hope? Analyst, KOL Give Mixed Views for CheckMate-227
July 31, 2019
- Astellas Secures Q1 Growth as Xtandi, Betanis Offset LOE Impact
July 31, 2019
- Eisai Halts Epilepsy Drug Studies after Death in Japan PI
July 31, 2019
- Pfizer Japan Seeks to Expand Bosulif Label into 1st-Line CML
July 31, 2019
- Otsuka Ups Half-Year Outlook on Bullish Jynarque
July 31, 2019
- Xtandi Filed for Hormone-Sensitive Prostate Cancer in Japan
July 31, 2019
- Over 1,000 GSK Staffers Worked from Home amid Govt’s Telework Campaign
July 30, 2019
- NEC Snaps Up Norway’s Bioinformatics Firm
July 30, 2019
- Sumitomo Dainippon Ekes Out Quarterly Growth as North America Sales Offset Japan Dip
July 30, 2019
- Shionogi’s Q1 Sales Sag 10.5% after Hefty Xofluza Milestone Gain
July 30, 2019
- Mitsubishi Tanabe’s Sales Fall 6.9% as Gilenya Snafu Takes Toll
July 30, 2019
- Lonsurf Gets EU Nod for Gastric Cancer: Taiho
July 30, 2019
- Nesp Biosame to Hit Japan Shelves on August 5
July 29, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
